• Bloomberg, Kyodo

  • SHARE

Japan is poised to buy more doses of the COVID-19 vaccine developed by Pfizer Inc. and BioNTech SE, a move that would pave the way for the country to immunize its adult population without using any of the shots it purchased from AstraZeneca PLC, which have been linked to rare blood clots.

Pfizer is expected to provide an additional 50 million doses by September in a contract that could be agreed on this month, government sources said Wednesday.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)